NEUPHORIA THERAPEUTICS INC NEUP
$3.38
-4.8% 52w: $3.38 – $20.00
Latest 13F among current holders filed 3 months ago (May 18, 2026)
Price — last 12 months
research preview data3.3811.6920.00
Aug 18, 2025 Jul 2, 2026
Institutional holders
19
-2 QoQ
13F value
$7.2M
+25.8% QoQ
Smart-money holders
4
signal tier ≥ 2
New smart buyers
1
Q1 2026
Institutional value by quarter
Number of holders
Who owns NEUP?
Q1 2026 filings| Fund | Type | Shares | Value | % of fund | Change |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP ★2 | Fundamental concentrated | 875.3K | $3.6M | — | 0.0% |
| AdvisorShares Investments LLC | Other | 155.4K | $632K | — | +15.8% |
| Shay Capital LLC | Quant stat arb | 151.0K | $615K | 0.1% | -10.7% |
| Balyasny Asset Management L.P. | Multistrat pod | 142.2K | $579K | 0.0% | New |
| VANGUARD CAPITAL MANAGEMENT LLC | Diversified mechanical | 98.5K | $401K | — | — |
| Squadron Capital Management LLC ★2 | Fundamental concentrated | 76.7K | $312K | — | New |
| GEODE CAPITAL MANAGEMENT, LLC | Index provider | 52.0K | $212K | — | +200.6% |
| Ikarian Capital, LLC ★2 | Fundamental diversified | 47.4K | $193K | — | Held |
| VANGUARD FIDUCIARY TRUST CO | Diversified mechanical | 33.6K | $137K | — | — |
| ADAR1 Capital Management, LLC | Other | 30.0K | $122K | 0.0% | Held |
| FNY Investment Advisers, LLC | Quant stat arb | 26.5K | $107K | — | Held |
| CITADEL ADVISORS LLC | Multistrat pod | 19.3K | $79K | 0.0% | New |
| BOOTHBAY FUND MANAGEMENT, LLC | Diversified mechanical | 14.0K | $57K | 0.0% | Held |
| Virtu Financial LLC | Market maker | 12.0K | $49K | — | New |
| COMMONWEALTH EQUITY SERVICES, LLC | Wealth advisor | 11.2K | $46K | 0.0% | +0.1% |
| Merck & Co., Inc. ★3 | Fundamental concentrated | 10.0K | $41K | — | Held |
| UBS Group AG | Bank broker | 2.3K | $9K | 0.0% | +40.2% |
| RHUMBLINE ADVISERS | Diversified mechanical | 202 | $822 | 0.0% | Held |
| MORGAN STANLEY | Bank broker | 58 | $236 | 0.0% | Held |
Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.
Explore related
Top funds holding NEUP
More healthcare stocks held by institutions